Friedman J H
Roger Williams Medical Center, Institute for Mental Health, Providence, Rhode Island 02908.
Mov Disord. 1994 May;9(3):321-4. doi: 10.1002/mds.870090308.
Among the tardive dyskinesia syndromes, dystonia can be the most difficult to treat. It may be severe to the point of being disabling, yet the patients may require antipsychotic medications for an even more disabling psychosis. Clozapine, an atypical neuroleptic drug that lacks extrapyramidal effects, may be the drug of choice for such patients. This report describes three patients with significant dystonia, previously disabled by their psychoses, who have been successfully managed with clozapine plus other agents for > 3 years.
在迟发性运动障碍综合征中,肌张力障碍可能是最难治疗的。它可能严重到致残的程度,但患者可能需要使用抗精神病药物来治疗更严重的致残性精神病。氯氮平是一种缺乏锥体外系效应的非典型抗精神病药物,可能是这类患者的首选药物。本报告描述了三名患有严重肌张力障碍的患者,他们之前因精神病而致残,使用氯氮平加其他药物成功治疗超过3年。